Photodynamic effect of novel hexa-iodinated quinono-cyanine dye on Staphylococcus aureus

Photodiagnosis Photodyn Ther. 2020 Sep:31:101866. doi: 10.1016/j.pdpdt.2020.101866. Epub 2020 Jun 11.

Abstract

Background: Staphylococcus aureus (S. aureus) is a Gram-positive bacteria and major human pathogen which can cause a wide variety of serious infections when it enters the bloodstream or internal tissues. Antimicrobial photodynamic therapy (APDT) utilizing a light-activated dye (photosensitizer) is a powerful method for in vitro and in vivo eradication of S. aureus and other pathogenic bacteria. However, the development of highly efficient, long-wavelength photosensitizers showing high phototoxicity to pathogens and low dark toxicity is still challenging.

Aim: To develop a highly efficient, long-wavelength photosensitizer for photodynamic inactivation of S. aureus.

Method: Synthesis of the new photosensitizer, hexa-iodinated quinono-cyanine dye IQCy and investigation of the dark and light-induced toxicity of this dye compared to known photosensitizers Chlorin e6 (Ce6) and HITC towards S. aureus.

Results: When exposed to 14.9 J/cm2 white LED light, 0.5 μM of IQCy, Ce6 and HITC inactivate, respectively, 99 %, 40 % and 30 % of S. aureus and at 0.05 μM and 27.9 J/cm2 - 71 %, 18 % and 9%, which is much better compared to Ce6 and HITC. IQCy exhibits no dark toxicity at least at 10 μM dye concentration.

Conclusions: IQCy demonstrates a more pronounced photodynamic inactivation of S. aureus as compared to Ce6 and HITC and can be employed for the eradication of these bacteria at lower concentration and reduced light dose.

Keywords: Antimicrobial photodynamic therapy; Iodinated quinono-cyanine; Photosensitizer; Staphylococcus aureus.

MeSH terms

  • Hexosaminidase A
  • Humans
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Staphylococcal Infections*
  • Staphylococcus aureus

Substances

  • Photosensitizing Agents
  • Hexosaminidase A